IMP2-IN-1

• CAT Number: I043565
• CAS Number: 1480482-51-6
• Molecular Formula: C21H14F3NO4
• Molecular Weight: 401.34
• Purity: ≥95%
• Synonyms: 2-[(4-phenylbenzoyl)amino]-5-(trifluoromethoxy)benzoic acid
• InChI: InChI=1S/C21H14F3NO4/c22-21(23,24)29-16-10-11-18(17(12-16)20(27)28)25-19(26)15-8-6-14(7-9-15)13-4-2-1-3-5-13/h1-12H,(H,25,26)(H,27,28)
• InChIKey: ACJZUAUURQGKNK-UHFFFAOYSA-N
• SMILES: C1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)NC3=C(C=C(C=C3)OC(F)(F)F)C(=O)O

IMP2-IN-1（Cat No.:I043565）is an investigational compound designed to inhibit the IMP2 protein, a member of the insulin-like growth factor (IGF) binding protein family. IMP2 plays a crucial role in regulating cell growth, differentiation, and metabolism by interacting with IGF pathways. By targeting IMP2, IMP2-IN-1 aims to modulate these pathways, potentially offering therapeutic benefits in conditions such as cancer, where dysregulated IGF signaling contributes to tumor growth and metastasis. Additionally, it may have applications in metabolic diseases or disorders related to abnormal cell proliferation and survival. Ongoing research is evaluating its efficacy and safety in clinical settings.